##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 73 Download : 77

##plugins.themes.academic_pro.article.main##

Abstract

Thyroid function is modulated by genetic and environmental factors, as well as other diseases and drugs such as gonads or sex steroids. The last category of drugs (sex steroids) modulates the activity of the thyroid gland. Gonadal steroids primarily affect thyroid function by altering the clearance of thyroxinebinding globulin (TBG). While estrogen administration leads to an increase in the serum concentration of TBG, androgen therapy leads to a decrease in the level of this binding protein. The influence of gonadal steroids on the clearance and concentration of TCH is modulated by the chemical structure of the steroid used, its chemical structure. This article discusses the role of thyroid sex steroids.

Keywords

structure Adenomyosis estrone testosterone

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Zamira Xalimova Yusufovna, & Nilufar Ishankulova Feruzjanovna. (2022). Study of the Role of Sex Steroids in the Nodulation of the Thyroid Gland and Uterus. Texas Journal of Medical Science, 13, 7–8. https://doi.org/10.62480/tjms.2022.vol13.pp7-8
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Ashrafyan, L.A. Pathogenetic prevention of cancer of the reproductive organs / L.A. Ashrafyan. - M., Dimitreid Graph Group, 2009. - 176 p.
  2. Bershtein, L.M. Oncoendocrinology / L.M. Berstein. - St. Petersburg. : Nauka, 2004. - 343 p.
  3. Hyperplastic processes of the organs of the female reproductive system: theory and practice /V.I. Kiselev, I.S. Sidorova, A.L. Unanyan, E.L. Muizhnek. - M. : Medpraktika, 2011. - S. 468.
  4. Bray F., Ferlay J., Soerjomataram I., Siege R.L., Torre L.A., Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers In 185 Countries.CA: A Cancer Journal for Clinicians. 2018. R. 1-31.
  5. Malignant neoplasms in Russia in 2017 (morbidity and mortality) / Ed. HELL. Kaprina, V.V. Starinsky, G.V. Petrova. Moscow: MNIOI im. P. A. Gertsen - branch of the Federal State Budgetary Institution "NMITs Radiology" of the Ministry of Health of Russia, 2018. 250 p.
  6. Kairbaev M.R., Chingisova Zh.K., Kukubasov E.K., Shalbaeva R.Sh., Dosakhanov Zh. Molecular markers of cervical and uterine cancer as prognostic factors // Clinical medicine of Kazakhstan. 2013. No. 3. S. 43-46.
  7. Hida K., Maishi N., Torii C., Hida Y. Tumor angiogenesis-characteristics of tumor endothelial cells.Inst. J.Clin. oncol. 2016.vol. 21. P. 206-221.